Targeting corneal disorders using gene therapy

Abstract

The cornea is an extensively studied model for genetic approaches due to its accessibility, transparency, stability, immune privilege and other physiological advantages achievable in both human and animal models. Gene therapy is imminent as a potential measure to treat inherited and acquired diseases of the cornea. Hundreds of experiments have been performed for the detection and identification, delivery, expression and recognition of possible treatments on various corneal disorder models. Viral, nonviral and hybrid vectors, DNA vaccination, RNA interference, enzyme modulation and other approaches have proved to be successful so far. The authors review a quick discussion on the physical, viral, nonviral and other modes of administration of genes, and the effects or challenges posed for treating various corneal disorders.

Keywords::

• cornea
• corneal disorders
• gene delivery systems
• gene therapy

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.